Global Variome shared LOVD
F12 (coagulation factor XII (Hageman factor))
LOVD v.3.0 Build 30b [
Current LOVD status
]
Register as submitter
|
Log in
Curator:
Christian Drouet
View all genes
View F12 gene homepage
View graphs about the F12 gene database
Create a new gene entry
View all transcripts
View all transcripts of gene F12
Create a new transcript information entry
View all variants
View all variants affecting transcripts
View unique variants in gene F12
View all variants in gene F12
Full data view for gene F12
Create a new data submission
View active genomic custom columns
Enable more genomic custom columns
View all individuals
View all individuals with variants in gene F12
Create a new data submission
View active custom columns
Enable more custom columns
View all diseases
View all diseases associated with gene F12
Create a new disease information entry
View available phenotype columns
View all screenings
View all screenings for gene F12
Create a new data submission
View active custom columns
Enable more custom columns
Submit new data
Full data view for gene F12
The variants shown are described using the NM_000505.3 transcript reference sequence.
Legend
Please note that a short description of a certain column can be displayed when you move your mouse cursor over the column's header and hold it still. Below, a more detailed description is shown per column.
Effect
: The variant's effect on the function of the gene/protein, displayed in the format 'R/C'. R is the value reported by the source (publication, submitter) and this classification may vary between records. C is the value concluded by the curator. Note that in some database the curator uses Summary records to give details on the classification of the variant.Values used: '+' indicating the variant affects function, '+?' probably affects function, '-' does not affect function, '-?' probably does not affect function, '?' effect unknown, '.' effect was not classified.
Exon
: number of exon/intron containing variant; 2 = exon 2, 12i = intron 12, 2i_7i = from intron 2 to intron 7, 8i_9 = intron 8/exon 9 boundary, _1 = 5' to exon 1, 18_ = 3' of exon 18, _1_18_ = encompassing the entire 18-exon gene
DNA change (cDNA)
: description of variant at DNA level, based on a coding DNA reference sequence (following HGVS recommendations); e.g. c.123C>T, c.123_145del, c.123_126dup. For deletions/duplications extending beyond the reference transcript resp. {0}/{2} is used to replace del/dup. Extent of the deletion/duplication should be specified using the genomic description (g.). "-" indicates the variant described on genomic level does not affect the coding DNA reference sequence.
RNA change
: description of variant at RNA level (following HGVS recommendations).
r.123c>u
r.? = unknown
r.(?) = RNA not analysed but probably transcribed copy of DNA variant
r.spl? = RNA not analysed but variant probably affects splicing
r.(spl?) = RNA not analysed but variant may affect splicing
r.0? = change expected to abolish transcription
Protein
: description of variant at protein level (following HGVS recommendations).
p.(Arg345Pro) = change predicted from DNA (RNA not analysed)
p.Arg345Pro = change derived from RNA analysis
p.? = unknown effect
p.0? = probably no protein produced
Allele
: On which allele is the variant located? Does not necessarily imply inheritance! 'Paternal' (confirmed or inferred), 'Maternal' (confirmed or inferred), 'Parent #1' or #2 for compound heterozygosity without having screened the parents, 'Unknown' for heterozygosity without having screened the parents, 'Both' for homozygozity.
Classification method
: The method used for the clinical classification of this variant.
All options:
ACMG
ACGS
EAHAD-CFDB
ENIGMA
IARC
InSiGHT
kConFab
other
Clinical classification
: Clinical classification of variant, preferably based on standardised criteria (e.g. ACMG), directed on the clinical consequences as published/submitted, indicated using an enriched system including inheritance: e.g. pathogenic, pathogenic (dominant), pathogenic (recessive), pathogenic (!), pathogenic (maternal), pathogenic (paternal). Standard inheritance is covered by dominant/recessive, imprinting by maternal/paternal. A '!' warns for exceptional circumstances to be explained in the 'Remarks' field (low penetrance, variants pathogenic in heterozygous state only, hypomorphic/hypermorphic variants, protective variants, etc.). Non-disease consequences (e.g. drug metabolism (pharmacogenetics), risk factor, blood group, tasting bitter) are indicated using additions to the benign classification; benign (dominant), benign (recessive), benign (!), etc. The value 'association' is used for variants associated with a phenotype and 'NA' for variants from in vitro/in silico records. NOTE: classification may differ from the opinion of the curator as given in a variant SUMMARY-record or the 'Functional effect concluded'). NOTE: pathogenic/likely pathogenic should go together with "variant (probably) affects function" In ClassFunctional.
All options:
pathogenic
pathogenic (dominant)
pathogenic (recessive)
pathogenic (!)
pathogenic (maternal)
pathogenic (paternal)
likely pathogenic
likely pathogenic (dominant)
likely pathogenic (recessive)
likely pathogenic (!)
likely pathogenic (maternal)
likely pathogenic (paternal)
VUS
VUS (!)
likely benign
likely benign (dominant)
likely benign (recessive)
likely benign (!)
likely benign (maternal)
likely benign (paternal)
benign
benign (dominant)
benign (recessive)
benign (!)
benign (maternal)
benign (paternal)
conflicting
association
NA
DNA change (genomic) (hg19)
: HGVS description of variant at DNA level, based on the genomic (chromosomal) DNA reference sequence; e.g. g.12345678C>T, g.12345679del, g.12345678_12345890dup
DNA change (hg38)
: HGVS description of variant at DNA level, based on the hg38 genomic (chromosomal) eference sequence; e.g. g.12345678C>T, g.12345679del, g.12345678_12345890dup
Published as
: listed only when different from "DNA change"; variant as reported originally (e.g. 521delT). Variants seen in animal models, tested in vitro, predicted from RNA analysis, etc. are described between brackets like c.(456C>G)
ISCN
: description of the variant according to ISCN nomenclature
DB-ID
: database ID of variant, grouping multiple observations of the same variant together, starting with the HGNC gene symbol, followed by an underscore (_) and a six digit number (e.g. DMD_012345). _000000 is used for variants where DNA was not analysed (change predicted from RNA analysis), variants seen in animal models or variants not seen in humans but functionally tested in vitro
Variant remarks
: remarks regarding variant described, e.g. germline mosaicism in mother, 345 kb deletion, muscle RNA analysed, not in 200 control chromosomes tested, on founder haplotype, etc.
Reference
: publication describing the variant submitted, incl. links to OMIM, PubMed or other source, e.g. "den Dunnen ASHG2003 P2346"
ClinVar ID
: ID of variant in ClinVar database
dbSNP ID
: the dbSNP ID
Origin
: Origin of variant/record: Germline = in all cells, De novo = in all cells, but not in either parent, Germline/De novo (untested) = in all cells, parents not tested (use only when De novo is likely, e.g. isolated/sporadic cases with dominant disease), Somatic = present in a subset of cells, but not in either parent, Uniparental disomy = from parental disomy (maternal or paternal), CLASSIFICATION record = submitter only sharing variant classification (note another report may share Individual data), SUMMARY record = master summary record from curator (may link to another database), In vitro (cloned) = data resulting from in vitro functional assays, animal model = data from animal model, Artefact = false positive variant call, DUPLICATE record = variant already described on another chromosome (e.g. unbalanced translocation, duplicating transposition, 2nd fusion transcript, etc.)
All options:
Germline
De novo
Germline/De novo (untested)
Somatic
Uniparental disomy
Uniparental disomy, maternal allele
Uniparental disomy, paternal allele
CLASSIFICATION record
SUMMARY record
In vitro (cloned)
In silico
animal model
Artefact
DUPLICATE record
Unknown
Not applicable
Segregation
: Indicates whether the variant segregates with the phenotype (yes), does not segregate with the phenotype (no) or segregation is unknown (?)
All options:
? = unknown
yes = segregates with phenotype
no = does not segregate with phenotype
- = not applicable
Frequency
: frequency in which the variant was found; e.g 5/760 chromosomes (in 5 of 760 chromosomes tested), 1/33 patients (in 1 of 33 patients analysed in study), 0.05 controls (in 5% of control cases tested)
Re-site
: restriction enzyme recognition site created (+) or destroyed (-); e.g. BglII+;BamHI-
VIP
: variant VIP-status was requested for matchmaking - need collaboration(s) to crack the case - please contact the submitter/curator. NOTE: to get VIP status ask the curator.
Methylation
: result of methylation test; GOM (gain of methylation), LOM (loss of methylation), 30% (30% methylated). NOTE: when several tests were done mention the method as well (e.g. MS-PCR 75%)
Template
: Template(s) used to detect the sequence variant; DNA (genomic DNA), RNA (cDNA) or protein
All options:
DNA
RNA = RNA (cDNA)
protein
? = unknown
Technique
: technique(s) used to identify the sequence variant.
All options:
? = unknown
ARMS = amplification refractory mutation system
arrayCGH = array for Comparative Genomic Hybridisation
arrayMET = array for methylation analysis
arraySEQ = array for resequencing
arraySNP = array for SNP typing
arrayCNV = array for Copy Number Variation (SNP and CNV probes)
ASO = allele-specific oligo hybridisation
BESS = Base Excision Sequence Scanning
CMC = Chemical Mismatch Cleavage
COBRA = Combined Bisulfite Restriction Analysis
CSCE = Conformation Sensitive Capillary Electrophoresis
CSGE = Conformation Sensitive Gel Electrophoresis
ddF = dideoxy Fingerprinting
DGGE = Denaturing-Gradient Gel-Electrophoresis
DHPLC = Denaturing High-Performance Liquid Chromatography
DOVAM = Detection Of Virtually All Mutations (SSCA variant)
DSCA = Double-Strand DNA Conformation Analysis
DSDI = Detection Small Deletions and Insertions
EMC = Enzymatic Mismatch Cleavage
expr = expression analysis
FISH = Fluorescent In-Situ Hybridisation
FISHf = fiberFISH
HD = HeteroDuplex analysis
HPLC = High-Performance Liquid Chromatography
IEF = IsoElectric Focussing
IHC = Immuno-Histo-Chemistry
Invader = Invader assay
MAPH = Multiplex Amplifiable Probe Hybridisation
MAQ = Multiplex Amplicon Quantification
MCA = Melting Curve Analysis, high-resolution (HRMA)
microscope = microscopic analysis (karyotype)
microsat = microsatellite genotyping
minigene = expression minigene construct
MIP = Molecular Inversion Probe amplification
MIPsm = single molecule Molecular Inversion Probe amplification
MLPA = Multiplex Ligation-dependent Probe Amplification
MLPA-ms = Multiplex Ligation-dependent Probe Amplification, methylation specific
MS = mass spectrometry
Northern = Northern blotting
NUC = nuclease digestion (RNAseT1, S1)
OM = optical mapping
PAGE = Poly-Acrylamide Gel-Electrophoresis
PCR = Polymerase Chain Reaction
PCRdd = PCR, digital droplet
PCRdig = PCR + restriction enzyme digestion
PCRh = PCR, haloplex
PCRlr = PCR, long-range
PCRm = PCR, multiplex
PCRms = PCR, methylation sensitive
PCRq = PCR, quantitative (qPCR)
PCRrp = PCR, repeat-primed (RP-PCR)
PCRsqd = PCR, semi-quantitative duplex
PE = primer extension (APEX, SNaPshot)
PEms = primer extension, methylation-sensitive single-nucleotide
PFGE = Pulsed-Field Gel-Electrophoresis (+Southern)
PTT = Protein Truncation Test
RFLP = Restriction Fragment Length Polymorphisms
RT-PCR = Reverse Transcription and PCR
RT-PCRq = Reverse Transcription and PCR, quantitative
SBE = Single Base Extension
SEQ = SEQuencing (Sanger)
SEQb = bisulfite SEQuencing
SEQp = pyroSequencing
SEQms = sequencing, methylation specific
SEQ-ON = next-generation sequencing - Oxford Nanopore
SEQ-NG = next-generation sequencing
SEQ-NG-RNA = next-generation sequencing RNA
SEQ-NG-H = next-generation sequencing - Helicos
SEQ-NG-I = next-generation sequencing - Illumina/Solexa
SEQ-NG-IT = next-generation sequencing - Ion Torrent
SEQ-NG-R = next-generation sequencing - Roche/454
SEQ-NG-S = next-generation sequencing - SOLiD
SEQ-PB = next-generation sequencing - Pacific Biosciences
SNPlex = SNPlex
Southern = Southern blotting
SSCA = Single-Strand DNA Conformation polymorphism Analysis (SSCP)
SSCAf = fluorescent SSCA (SSCP)
STR = Short Tandem Repeat
TaqMan = TaqMan assay
Western = Western blotting
- = not applicable
Tissue
: tissue type used for analysis
Remarks
: remarks regarding the screening like WGS (whole genome sequencing), WES (whole exome sequencing, gene panel (incl. a list of genes analysed), etc.
ID_report
: ID of the individual that can be publically shared, e.g. as listed in a publication
Reference
: reference to publication describing the individual/family, possibly giving more phenotypic details than listed in this database entry, incl. link to PubMed or other source, e.g. "den Dunnen ASHG2003 P2346"
Remarks
: remarks about the individual
Gender
: gender individual
All options:
? = unknown
- = not applicable
F = female
M = male
rF = raised as female
rM = raised as male
Consanguinity
: indicates whether the parents are related (consanguineous), not related (non-consanguineous) or whether consanguinity is not known (unknown)
All options:
no = non-consanguineous parents
yes = consanguineous parents
likely = consanguinity likely
? = unknown
- = not applicable
Country
: where (country) does the individual live/recently came from. Give additional details (population, specific sub-group) and when parents come from different countries in "Population". Belgium = individual lives in/recently came from Belgium, (France) = reported by laboratory in France, individual's country of origin not sure
All options:
? (unknown)
- (not applicable)
Afghanistan
(Afghanistan)
Albania
(Albania)
Algeria
(Algeria)
American Samoa
(American Samoa)
Andorra
(Andorra)
Angola
(Angola)
Anguilla
(Anguilla)
Antarctica
(Antarctica)
Antigua and Barbuda
(Antigua and Barbuda)
Argentina
(Argentina)
Armenia
(Armenia)
Aruba
(Aruba)
Australia
(Australia)
Austria
(Austria)
Azerbaijan
(Azerbaijan)
Bahamas
(Bahamas)
Bahrain
(Bahrain)
Bangladesh
(Bangladesh)
Barbados
(Barbados)
Belarus
(Belarus)
Belgium
(Belgium)
Belize
(Belize)
Benin
(Benin)
Bermuda
(Bermuda)
Bhutan
(Bhutan)
Bolivia
(Bolivia)
Bosnia and Herzegovina
(Bosnia and Herzegovina)
Botswana
(Botswana)
Bouvet Island
(Bouvet Island)
Brazil
(Brazil)
British Indian Ocean Territory
(British Indian Ocean Territory)
Brunei Darussalam
(Brunei Darussalam)
Bulgaria
(Bulgaria)
Burkina Faso
(Burkina Faso)
Burundi
(Burundi)
Cambodia
(Cambodia)
Cameroon
(Cameroon)
Canada
(Canada)
Cape Verde
(Cape Verde)
Cayman Islands
(Cayman Islands)
Central African Republic
(Central African Republic)
Central Europe
Chad
(Chad)
Chile
(Chile)
China
(China)
Christmas Island
(Christmas Island)
Cocos (Keeling Islands)
(Cocos (Keeling Islands))
Colombia
(Colombia)
Comoros
(Comoros)
Congo
(Congo)
Cook Islands
(Cook Islands)
Costa Rica
(Costa Rica)
Cote D'Ivoire (Ivory Coast)
(Cote D'Ivoire (Ivory Coast))
Croatia (Hrvatska)
(Croatia (Hrvatska))
Cuba
(Cuba)
Cyprus
(Cyprus)
Czech Republic
(Czech Republic)
Denmark
(Denmark)
Djibouti
(Djibouti)
Dominica
(Dominica)
Dominican Republic
(Dominican Republic)
East Timor
(East Timor)
Ecuador
(Ecuador)
Egypt
(Egypt)
El Salvador
(El Salvador)
England
(England)
Equatorial Guinea
(Equatorial Guinea)
Eritrea
(Eritrea)
Estonia
(Estonia)
Ethiopia
(Ethiopia)
Falkland Islands (Malvinas)
(Falkland Islands (Malvinas))
Faroe Islands
(Faroe Islands)
Fiji
(Fiji)
Finland
(Finland)
France
(France)
Gabon
(Gabon)
Gambia
(Gambia)
Georgia
(Georgia)
Germany
(Germany)
Ghana
(Ghana)
Gibraltar
(Gibraltar)
Greece
(Greece)
Greenland
(Greenland)
Grenada
(Grenada)
Guadeloupe
(Guadeloupe)
Guam
(Guam)
Guatemala
(Guatemala)
Guiana, French
(Guiana, French)
Guinea
(Guinea)
Guinea-Bissau
(Guinea-Bissau)
Guyana
(Guyana)
Haiti
(Haiti)
Heard and McDonald Islands
(Heard and McDonald Islands)
Honduras
(Honduras)
Hong Kong
(Hong Kong)
Hungary
(Hungary)
Iceland
(Iceland)
India
(India)
Indonesia
(Indonesia)
Iran
(Iran)
Iraq
(Iraq)
Ireland
(Ireland)
Israel
(Israel)
Italy
(Italy)
Jamaica
(Jamaica)
Japan
(Japan)
Jordan
(Jordan)
Kazakhstan
(Kazakhstan)
Kenya
(Kenya)
Kiribati
(Kiribati)
Korea
(Korea)
Korea, North (People's Republic)
(Korea, North (People's Republic))
Korea, South (Republic)
(Korea, South (Republic))
Kosovo
(Kosovo)
Kuwait
(Kuwait)
Kyrgyzstan (Kyrgyz Republic)
(Kyrgyzstan (Kyrgyz Republic))
Laos
(Laos)
Latvia
(Latvia)
Lebanon
(Lebanon)
Lesotho
(Lesotho)
Liberia
(Liberia)
Libya
(Libya)
Liechtenstein
(Liechtenstein)
Lithuania
(Lithuania)
Luxembourg
(Luxembourg)
Macau
(Macau)
Macedonia
(Macedonia)
Madagascar
(Madagascar)
Malawi
(Malawi)
Malaysia
(Malaysia)
Maldives
(Maldives)
Mali
(Mali)
Mallorca
(Mallorca)
Malta
(Malta)
Marshall Islands
(Marshall Islands)
Martinique
(Martinique)
Mauritania
(Mauritania)
Mauritius
(Mauritius)
Mayotte
(Mayotte)
Mexico
(Mexico)
Micronesia
(Micronesia)
Moldova
(Moldova)
Monaco
(Monaco)
Mongolia
(Mongolia)
Montserrat
(Montserrat)
Morocco
(Morocco)
Mozambique
(Mozambique)
Myanmar
(Myanmar)
Namibia
(Namibia)
Nauru
(Nauru)
Nepal
(Nepal)
Netherlands
(Netherlands)
Netherlands Antilles
(Netherlands Antilles)
Neutral Zone (Saudia Arabia/Iraq)
(Neutral Zone (Saudia Arabia/Iraq))
New Caledonia
(New Caledonia)
New Zealand
(New Zealand)
Nicaragua
(Nicaragua)
Niger
(Niger)
Nigeria
(Nigeria)
Niue
(Niue)
Norfolk Island
(Norfolk Island)
Northern Ireland
(Northern Ireland)
Northern Mariana Islands
(Northern Mariana Islands)
Norway
(Norway)
Oman
(Oman)
Pakistan
(Pakistan)
Palau
(Palau)
Palestine
(Palestine)
Panama
(Panama)
Papua New Guinea
(Papua New Guinea)
Paraguay
(Paraguay)
Peru
(Peru)
Philippines
(Philippines)
Pitcairn
(Pitcairn)
Poland
(Poland)
Polynesia, French
(Polynesia, French)
Portugal
(Portugal)
Puerto Rico
(Puerto Rico)
Qatar
(Qatar)
Reunion
(Reunion)
Romania
(Romania)
Russia
(Russia)
Russian Federation
(Russian Federation)
Rwanda
(Rwanda)
S. Georgia and S. Sandwich Isls.
(S. Georgia and S. Sandwich Isls.)
Saint Kitts and Nevis
(Saint Kitts and Nevis)
Saint Lucia
(Saint Lucia)
Saint Vincent and The Grenadines
(Saint Vincent and The Grenadines)
Samoa
(Samoa)
San Marino
(San Marino)
Sao Tome and Principe
(Sao Tome and Principe)
Saudi Arabia
(Saudi Arabia)
Scotland
(Scotland)
Senegal
(Senegal)
Serbia
(Serbia)
Seychelles
(Seychelles)
Sierra Leone
(Sierra Leone)
Singapore
(Singapore)
Slovakia (Slovak Republic)
(Slovakia (Slovak Republic))
Slovenia
(Slovenia)
Solomon Islands
(Solomon Islands)
Somalia
(Somalia)
South Africa
(South Africa)
Southern Territories, French
(Southern Territories, French)
Soviet Union (former)
(Soviet Union (former))
Spain
(Spain)
Sri Lanka
(Sri Lanka)
St. Helena, Ascension and Tristan da
Cunha
(St. Helena, Ascension and Tristan da
Cunha)
St. Pierre and Miquelon
(St. Pierre and Miquelon)
Sudan
(Sudan)
Sudan, South
(Sudan, South)
Suriname
(Suriname)
Svalbard and Jan Mayen Islands
(Svalbard and Jan Mayen Islands)
Swaziland
(Swaziland)
Sweden
(Sweden)
Switzerland
(Switzerland)
Syria
(Syria)
Taiwan
(Taiwan)
Tajikistan
(Tajikistan)
Tanzania
(Tanzania)
Thailand
(Thailand)
Togo
(Togo)
Tokelau
(Tokelau)
Tonga
(Tonga)
Trinidad and Tobago
(Trinidad and Tobago)
Tunisia
(Tunisia)
Turkey
(Turkey)
Turkmenistan
(Turkmenistan)
Turks and Caicos Islands
(Turks and Caicos Islands)
Tuvalu
(Tuvalu)
Uganda
(Uganda)
Ukraine
(Ukraine)
United Arab Emirates
(United Arab Emirates)
United Kingdom (Great Britain)
(United Kingdom (Great Britain))
United States
(United States)
Uruguay
(Uruguay)
US Minor Outlying Islands
(US Minor Outlying Islands)
Uzbekistan
(Uzbekistan)
Vanuatu
(Vanuatu)
Vatican City State (Holy See)
(Vatican City State (Holy See))
Venezuela
(Venezuela)
Viet Nam
(Viet Nam)
Virgin Islands (British)
(Virgin Islands (British))
Virgin Islands (US)
(Virgin Islands (US))
Wales
(Wales)
Wallis and Futuna Islands
(Wallis and Futuna Islands)
Western Sahara
(Western Sahara)
Yemen
(Yemen)
Yugoslavia
(Yugoslavia)
Zaire
(Zaire)
Zambia
(Zambia)
Zimbabwe
(Zimbabwe)
Population
: population the individual (or ancestors) belongs to; e.g. white, gypsy, Jewish-Ashkenazi, Africa-N, Sardinia, etc.
Age at death
: age at which the individual deceased (when applicable):
35y = 35 years
>43y = still alive at 43y
04y08m = 4 years and 8 months
00y00m01d12h = 1 day and 12 hours
18y? = around 18 years
30y-40y = between 30 and 40 years
>54y = older than 54
? = unknown
VIP
: individual/phenotype VIP-status was requested for matchmaking - need collaboration(s) to crack the case - please contact the submitter/curator. NOTE: to get VIP status ask the curator.
Data_av
: are additional data available upon request: e.g. pedigree (yes/no/?)
Treatment
: treatment of patient
How to query this table
All list views have search fields which can be used to search data. You can search for a complete word or you can search for a part of a search term. If you enclose two or more words in double quotes, LOVD will search for the combination of those words only exactly in the order you specify. Note that search terms are case-insensitive and that wildcards such as * are treated as normal text! For all options, like "and", "or", and "not" searches, or searching for prefixes or suffixes, see the table below.
Operator
Column type
Example
Matches
Text
Arg
all entries containing 'Arg'
space
Text
Arg Ser
all entries containing 'Arg' and 'Ser'
|
Text
Arg|Ser
all entries containing 'Arg' or 'Ser'
!
Text
!fs
all entries not containing 'fs'
^
Text
^p.(Arg
all entries beginning with 'p.(Arg'
$
Text
Ser)$
all entries ending with 'Ser)'
=""
Text
=""
all entries with this field empty
=""
Text
="p.0"
all entries exactly matching 'p.0'
!=""
Text
!=""
all entries with this field not empty
!=""
Text
!="p.0"
all entries not exactly matching 'p.0?'
combination
Text
*|Ter !fs
all entries containing '*' or 'Ter' but not containing 'fs'
Date
2020
all entries matching the year 2020
|
Date
2020-03|2020-04
all entries matching March or April, 2020
!
Date
!2020-03
all entries not matching March, 2020
<
Date
<2020
all entries before the year 2020
<=
Date
<=2020-06
all entries in or before June, 2020
>
Date
>2020-06
all entries after June, 2020
>=
Date
>=2020-06-15
all entries on or after June 15th, 2020
combination
Date
2019|2020 <2020-03
all entries in 2019 or 2020, and before March, 2020
Numeric
23
all entries exactly matching 23
|
Numeric
23|24
all entries exactly matching 23 or 24
!
Numeric
!23
all entries not exactly matching 23
<
Numeric
<23
all entries lower than 23
<=
Numeric
<=23
all entries lower than, or equal to, 23
>
Numeric
>23
all entries higher than 23
>=
Numeric
>=23
all entries higher than, or equal to, 23
combination
Numeric
>=20 <30 !23
all entries with values from 20 to 29, but not equal to 23
Some more advanced examples:
Example
Matches
Asian
all entries containing 'Asian', 'asian', including 'Caucasian', 'caucasian', etc.
Asian !Caucasian
all entries containing 'Asian' but not containing 'Caucasian'
Asian|African !Caucasian
all entries containing 'Asian' or 'African', but not containing 'Caucasian'
"South Asian"
all entries containing 'South Asian', but not containing 'South East Asian'
To sort on a certain column, click on the column header or on the arrows. If that column is already selected to sort on, the sort order will be swapped. The column currently sorted on has a darker blue background color than the other columns. The up and down arrows next to the column name indicate the current sorting direction. When sorting on any field other than the default, LOVD will sort secondarily on the default sort column.
38 entries on 1 page. Showing entries 1 - 38.
10 per page
25 per page
50 per page
100 per page
Legend
How to query
Effect
Exon
DNA change (cDNA)
RNA change
Protein
Allele
Classification method
Clinical classification
DNA change (genomic) (hg19)
DNA change (hg38)
Published as
ISCN
DB-ID
Variant remarks
Reference
ClinVar ID
dbSNP ID
Origin
Segregation
Frequency
Re-site
VIP
Methylation
Template
Technique
Tissue
Remarks
Disease
ID_report
Reference
Remarks
Gender
Consanguinity
Country
Population
Age at death
VIP
Data_av
Treatment
Panel size
Owner
+/+
9
c.983C>A
r.(?)
p.(Thr328Lys)
Unknown
-
pathogenic
g.176831232G>T
g.177404231G>T
F12(NM_000505.3):c.983C>A (p.T328K), F12(NM_000505.4):c.983C>A (p.T328K)
-
F12_000008
VKGL data sharing initiative Nederland
-
-
-
CLASSIFICATION record
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
+/+
9
c.983C>A
r.(?)
p.(Thr328Lys)
Parent #1
ACMG
pathogenic
g.176831232G>T
g.177404231G>T
-
-
F12_000008
-
Journal: Charignon 2018
ClinVar-000001169
rs118204456
Germline
yes
-
-
-
-
DNA
SEQ
-
-
HAE1;HAE2
FamPatIII1
PubMed: Charignon 2018
,
Journal: Charignon 2018
2-generation family, 2 affected (2F)
F
no
France
-
-
-
-
-
3
Christian Drouet
+/.
9
c.983C>A
r.(?)
p.(Thr328Lys)
Unknown
-
pathogenic
g.176831232G>T
g.177404231G>T
F12(NM_000505.3):c.983C>A (p.T328K), F12(NM_000505.4):c.983C>A (p.T328K)
-
F12_000008
VKGL data sharing initiative Nederland
-
-
-
CLASSIFICATION record
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
+/+
9
c.983C>A
r.(?)
p.(Thr328Lys)
Unknown
ACMG
pathogenic
g.176831232G>T
g.177404231G>T
-
-
F12_000008
Numerous Brazilian pedigrees have been recorded as carrying a c.983C>A variant, with 94 families and 176 heterozygous patients. Incomplete prenetrance: 79 asymptomatic relatives within 180 carriers of a c.983C>A variant. The c.983C>A variant meets the ACMG criteria to be characterized pathogenic PP1, PM1, PM5, PS3, PS4_Mod
Journal: Veronez 2018
Journal: Veronez 2021
Journal: Gabriel 2025
ClinVar-VCV000001169.8
rs118204456
Germline
yes
0.000004 (GnomAD_exome)
-
-
-
DNA
SEQ
blood
-
HAE3
-
Journal: Veronez 2018
Journal: Veronez 2021
Journal: Gabriel 2025
Numerous Brazilian pedigrees have been recorded as carrying a c.1032C>A variant, with 94 families and 176 heterozygous carriers. Incomplete penetrance demonstrated in a family where 9/19 symptomatic individuals have been recorded. The course of pregnancies in women diagnosed with HAE-nC1-INH has been described for 7 carriers of a F12 variant.
-
no
Brazil
-
-
-
-
-
176
Christian Drouet
+/+
9
c.983C>A
r.(?)
p.(Thr328Lys)
Both (homozygous)
ACMG
pathogenic
g.176831232G>T
g.177404231G>T
c.[983C>A];[983C>A]
-
F12_000008
Two Brazilian pedigrees have been recorded as segregating a c.983 C>A;(p.Thr328Lys) variant, with 1 homozygous carrier, one male and one female, respectively in each family. Fourteen affected individuals. Homozygosity for c.983C>A variant lead to develop disease symptoms in males - heterozygous male carriers normally do not develop disease symptoms - and a more severe disease phenotype in females compared to patients heterozygous for the F12 c.983 C>A variant.
Journal: Grumach 2016
Journal: Stieber 2014
ClinVar-VCV000001169.8
rs118204456
Germline
yes
0.000004 (GnomAD_exome)
-
-
-
DNA
SEQ
blood
-
HAE3
-
Journal: Grumach 2016
Two Brazilian families are presenting with homozygous carriers of a c.983C>A variant, one male and one female
-
-
Brazil
-
-
-
-
-
14
Christian Drouet
+/+
9
c.983C>A
r.(?)
p.(Thr328Lys)
Unknown
ACMG
pathogenic
g.176831232G>T
g.177404231G>T
-
-
F12_000008
Nine families and 23 affected individuals Important Italian cohort from that has been assessed a prevalence of 1:1.4 × E6 for HAE-FXII. The c.983C>A variant meets the ACMG criteria to be characterized pathogenic PP1, PM1, PM5, PS3, PS4_Mod
Journal: Bova 2020
ClinVar-VCV000001169.8
rs118204456
Germline
yes
-
-
-
-
DNA
SEQ
blood
-
HAE3
-
-
Nine independent Italian kindreds have been shown as carrying a c.983C>A variant, with 23/43 affected individuals, 32 females and 11 males
-
-
Italy
-
-
-
-
-
23
Christian Drouet
+/+
9
c.983C>A
r.(?)
p.(Thr328Lys)
Unknown
ACMG
pathogenic
g.176831232G>T
g.177404231G>T
c.1032C>A
-
F12_000008
The first French pedigree affected by HAE-F12. Incomplete penetrance: 8/13 affected individuals. Haplotype analyses with use of SNPs at the F12 locus provided evidence that the French family and 3 of the German families reported by Dewald and Bork (2006) shared a common founder. Plasma displays a gain-of-function of kallikrein-kinin system; p.(Thr328Lys) exhibits a lower glycosylation, with subsequent increased autoactivation of zymogen F12. Thr to Lys transition has consequence on the protein’s folding and conformation, with an open or relaxed conformation facilitating the access of kallikrein and plasmin and exposing cryptic proteolytic targets for thrombin that are normally concealed and not accessible in the compact conformation of FXII. The c.983C>A variant meets the ACMG criteria to be characterized pathogenic PP1, PM1, PM5, PS3, PS4_Mod.
Journal: Martin 2001
Journal: Cichon 2006
Journal: Björkvist 2015
Journal: de Maat 2016
ClinVar-VCV000001169.8
rs118204456
Germline
yes
0.000004 (1/234142, GnomAD_exome)
-
-
-
DNA
SEQ
-
-
HAE3
-
Journal: Cichon 2006
Journal: Björkvist 2015
Journal: de Maat 2016
A French pedigree with 8 affected individuals within 13 carriers of a c.983C>A variant
-
-
France
-
-
-
-
-
8
Christian Drouet
+/.
9
c.983C>A
r.(?)
p.(Thr328Lys)
Unknown
ACMG
pathogenic
g.176831232G>T
g.177404231G>T
c.1032C>A
-
F12_000008
Four independent German kindreds have been found as carrying a c.983C>A variant
Journal: Dewald 2006
ClinVar-VCV000001169.8
rs118204456
Germline
yes
-
-
-
-
DNA
SEQ
blood
-
HAE3
-
Journal: Dewald 2006
Four independent German kindreds have been found as carrying a c.983C>A variant Family 1, n=2 Family 2, n=5 Family 3, n=6 Family 4, n=6
F
no
Germany
-
-
-
-
-
19
Christian Drouet
+/+
9
c.983C>A
r.(?)
p.(Thr328Lys)
Unknown
ACMG
pathogenic
g.176831232G>T
g.177404231G>T
-
-
F12_000008
First Australian case with HAE-FXII. The c.983C>A variant meets the ACMG criteria to be characterized pathogenic PP1, PM1, PM5, PS3, PS4_Mod
Journal: Bell 2008
-
-
Germline
yes
-
-
-
-
DNA
SEQ
blood
-
HAE3
-
-
Single family
F
no
Australia
-
-
-
-
-
1
Christian Drouet
+/+
9
c.983C>A
r.(?)
p.(Thr328Lys)
Unknown
ACMG
pathogenic
g.176831232G>T
g.177404231G>T
-
-
F12_000008
3 female individuals have been shown as affected. A single male carrier of c.983C>A variant is shown asymptomatic. The c.983C>A variant meets the ACMG criteria to be characterized pathogenic PP1, PM1, PM5, PS3, PS4_Mod
Journal: Prieto 2009
ClinVar-VCV000001169.8
rs118204456
Germline
yes
-
-
-
-
DNA
SEQ
blood
-
HAE3
-
-
Single family
F
no
Spain
-
-
-
-
-
3
Christian Drouet
+/+
9
c.983C>A
r.(?)
p.(Thr328Lys)
Unknown
ACMG
pathogenic
g.176831232G>T
g.177404231G>T
-
-
F12_000008
A single Canadian pedigree with 6 affected female individuals. Affected females have polymorphisms associated with lower levels of both APP and ACE, the major enzymes responsible for bradykinin catabolism. Three patients also carry the A allele of SNP rs3788853 in the XPNPEP2 gene, which may have contributed to the phenotype, making this observation the first one with multiple genes that might contribute to estrogen-dependent or estrogen associated HAE-F12. But this allele is also found in 10 unaffected family members. The c.983C>A variant meets the ACMG criteria to be characterized pathogenic PP1, PM1, PM5, PS3, PS4_Mod
Journal: Duan 2009
-
-
Germline
yes
-
-
-
-
DNA
SEQ
blood
-
HAE3
-
-
A single Canadian family with 6 symptomatic carriers of a c.983C>A variant
F
no
Canada
-
-
-
-
-
6
Christian Drouet
+/+
9
c.983C>A
r.(?)
p.(Thr328Lys)
Unknown
ACMG
pathogenic
g.176831232G>T
g.177404231G>T
-
-
F12_000008
The c.983C>A variant meets the ACMG criteria to be characterized pathogenic PP1, PM1, PM5, PS3, PS4_Mod
Journal: Bork 2009
Journal: Bork 2023
-
-
Germline
yes
-
-
-
-
DNA
SEQ
blood
-
HAE3
-
Journal: Bork 2009
Additional 10 German pedigrees shown as carrying a c.983C>A variant Female individuals are affected
F
no
Germany
-
-
-
-
-
45
Christian Drouet
+/.
9
c.983C>A
r.(?)
p.(Thr328Lys)
Unknown
ACMG
pathogenic
g.176831232G>T
g.177404231G>T
-
-
F12_000008
A single French pedigree with women and man. C1Inh function drops of 10% to 40% compared to normal in female individuals, in line with the cleavage of the serpin from 105 to 95 kd without development of serpin-protease association, suggesting p.(Met328Lys) beyond the control of C1-INH
Journal: Martin 2007
ClinVar-VCV000001169
rs118204456
Germline
yes
-
-
-
-
DNA
SEQ
blood
-
HAE3
-
-
A French pedigree with affected man (n=1) and women (n=2) Incomplete penetrance: 3/7 are affected
-
no
France
-
-
-
-
-
3
Christian Drouet
+/+
9
c.983C>A
r.(?)
p.(Thr328Lys)
Unknown
ACMG
pathogenic
g.176831232G>T
g.177404231G>T
-
-
F12_000008
Nine families with 29 affected individuals. Symptomatic individuals have been found as carriers of a c.-2399C variant of XPNPEP2 gene, and a DD or ID polymporphism of ACE gene.
Journal: Piñero-Saavedra 2016
ClinVar-VCV000001169.8
rs118204456
Germline/De novo (untested)
yes
0.000004 (GnomAD_exome)
-
-
-
DNA
SEQ
blood
-
HAE3
-
Journal: Piñero-Saavedra 2016
Prospective Spanish cohort study with 9 families and 24 symptomatic individuals
-
no
Spain
-
-
-
-
-
24
Christian Drouet
+/+
9
c.983C>A
r.(?)
p.(Thr328Lys)
Unknown
ACMG
pathogenic
g.176831232G>T
g.177404231G>T
-
-
F12_000008
The c.983C>A variant meets the ACMG criteria to be characterized pathogenic PP1, PM1, PM5, PS3, PS4_Mod
Journal: Moreno 2015
ClinVar-VCV000001169.8
rs118204456
Germline
yes
0.000004 (GnomAD_exome)
-
-
-
DNA
SEQ
blood
-
HAE3
-
Journal: Moreno 2015
Four Brazilian kindreds have been reported as carrying a c.983C>A variant, with 8/16 affected individuals
-
no
Brazil
-
-
-
-
-
8
Christian Drouet
+/.
9
c.983C>A
r.(?)
p.(Thr328Lys)
Unknown
ACMG
pathogenic
g.176831232G>T
g.177404231G>T
-
-
F12_000008
Thirteen kindreds from North-Western Spain have been found as carrying a c.983C>A variant, with 29 affected individuals
Journal: Marcos 2012
ClinVar-VCV000001169.8
rs118204456
Germline
yes
-
-
-
-
DNA
SEQ
blood
-
HAE3
-
Journal: Marcos 2012
Thirteen kindreds from North-West Spain, with 29 affected individuals
-
no
Spain
-
-
-
-
-
29
Christian Drouet
+/+
9
c.983C>A
r.(?)
p.(Thr328Lys)
Unknown
ACMG
pathogenic
g.176831232G>T
g.177404231G>T
-
-
F12_000008
The c.983C>A variant meets the ACMG criteria to be characterized pathogenic PP1, PM1, PM5, PS3, PS4_Mod
Journal: Baeza 2011
-
-
Germline
yes
-
-
-
-
DNA
SEQ
blood
-
HAE3
-
Journal: Baeza 2011
Single family
F
no
Morocco
-
-
-
-
-
3
Christian Drouet
+/+
9
c.983C>A
r.(?)
p.(Thr328Lys)
Unknown
ACMG
pathogenic
g.176831232G>T
g.177404231G>T
-
-
F12_000008
Two families with 5 affected female individuals; 3 are presenting with severe obstetrical complications
Journal: Picone 2010
-
-
Germline
yes
-
-
-
-
DNA
SEQ
blood
-
HAE3
-
Journal: Picone 2010
Symptoms and obstetrical complications of women in two families with HAE attributable to the c.983C>A variant in the F12 gene. Family 1, n=2 Family 2, n=3
F
-
France
-
-
-
-
-
5
Christian Drouet
+/+
9
c.983C>A
r.(?)
p.(Thr328Lys)
Unknown
ACMG
pathogenic
g.176831232G>T
g.177404231G>T
-
-
F12_000008
A Spanish kindred has been shown as carrying a c.983C>A variant, with 2 affected individuals
Journal: Veronez 2019
-
-
Germline
yes
-
-
-
-
DNA
SEQ-NG
blood
-
HAE3
-
Journal: Veronez 2019
Single family
F
no
Spain
-
-
-
-
-
2
Christian Drouet
+/+
9
c.983C>A
r.(?)
p.(Thr328Lys)
Unknown
ACMG
pathogenic
g.176831232G>T
g.177404231G>T
-
-
F12_000008
Four independent kindreds have been found as carrying a c.983C>A variant. Family 1, n=5 (female) Family 2, n=7 (female) Family 3, n=1 (female) Family 4, n=2 (female) All carriers also carry the same combined SNPs already described by Cichon 2006, demonstrating a common ancestor. The c.983C>A variant meets the ACMG criteria to be characterized pathogenic PP1, PM1, PM5, PS3, PS4_Mod
Journal: Firinu 2015
ClinVar-VCV000001170.4
rs118204456
Germline
yes
-
-
-
-
DNA
SEQ
blood
-
HAE3
-
Journal: Firinu 2015
Four Sardininan independent kindreds have been found as carrying a c.983C>A variant
F
no
Italy
Sardinian
-
-
-
-
15
Christian Drouet
+/+
9
c.983C>A
r.(?)
p.(Thr328Lys)
Unknown
ACMG
pathogenic
g.176831232G>T
g.177404231G>T
-
-
F12_000008
A single Italian pedigree with 3 affected female individuals. The patients also carry the same combination of SNPs already observed in the first description by Cichon et al 2006, demonstrating c983C>A as a common ancestral variant among affected individuals in western Europe. The c.983C>A variant meets the ACMG criteria to be characterized pathogenic PP1, PM1, PM5, PS3, PS4_Mod
Journal: Nagy 2009
-
-
Germline
yes
-
-
-
-
DNA
SEQ
blood
-
HAE3
-
Journal: Nagy 2009
The first British pedigree ever shown as carrying a c.983C>A variant, with 3 affected female individuals
F
-
United Kingdom (Great Britain)
-
-
-
-
-
3
Christian Drouet
+/+
9
c.983C>A
r.(?)
p.(Thr328Lys)
Unknown
ACMG
pathogenic
g.176831232G>T
g.177404231G>T
-
-
F12_000008
24 French pedigrees have been shown as carrying a c.983C>A variant, with 37/57 affected individuals. Family origin: 12/24 from Northern Africa. The c.983C>A variant meets the ACMG criteria to be characterized pathogenic PP1, PM1, PM5, PS3, PS4_Mod.
Journal: Deroux 2016
ClinVar-VCV000001169
rs118204456
Germline
yes
-
-
-
-
DNA
SEQ
blood
-
HAE3
-
Journal: Deroux 2016
24 French pedigrees have been shown as carrying a c.983C>A variant
-
no
France
-
-
-
-
-
37
Christian Drouet
+/.
9
c.983C>A
r.(?)
p.(Thr328Lys)
Unknown
ACMG
pathogenic
g.176831232G>T
g.177404231G>T
-
-
F12_000008
-
Journal: Mendoza-Alvarez 2022
-
-
Germline
yes
-
-
-
-
DNA
SEQ
blood
-
HAE3
Fam2
Journal: Mendoza-Alvarez 2022
3-generation family, 4 affected, father/3 daughters
F;M
no
Spain
-
-
-
-
-
4
Christian Drouet
+/+
9
c.983C>A
r.(?)
p.(Thr328Lys)
Unknown
-
pathogenic
g.176831232G>T
g.177404231G>T
F12(NM_000505.3):c.983C>A (p.T328K), F12(NM_000505.4):c.983C>A (p.T328K)
-
F12_000008
VKGL data sharing initiative Nederland
-
-
-
CLASSIFICATION record
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
+/+
9
c.983C>A
r.(?)
p.(Thr328Lys)
Unknown
ACMG
pathogenic
g.176831232G>T
g.177404231G>T
-
-
F12_000008
Isolated HAE-nC1-INH individuals carrying a c.983C>A variant (10 families): Occurrence of only one symptomatic patient per family, who had no family history of angioedema but who had symptom-free relatives carrying the same HAE-linked c.983C>A variant. The c.983C>A variant meets the ACMG criteria to be characterized pathogenic PP1, PM1, PM5, PS3, PS4_Mod
Journal: Bork 2023
ClinVar-000001169
rs118204456
Germline
yes
0.00001
-
-
-
DNA
SEQ
blood
-
HAE3
-
Journal: Bork 2023
Ten independent families: 10 isolated HAE-nC1-INH individuals carrying a c.983C>A variant in F12 gene
-
no
Germany
-
-
-
-
-
10
Christian Drouet
+/+
9
c.983C>A
r.(?)
p.(Thr328Lys)
Unknown
ACMG
pathogenic
g.176831232G>T
g.177404231G>T
-
-
F12_000008
The c.983C>A variant meets the ACMG criteria to be characterized pathogenic PP1, PM1, PM5, PS3, PS4_Mod
Journal: Hentges 2009
-
-
Germline
yes
-
-
-
-
DNA
SEQ
blood
-
HAE3
-
Journal: Hentges 2009
Single family with a single female affected individual
F
no
Luxembourg
-
-
-
-
-
1
Christian Drouet
+/+
9
c.983C>A
r.(?)
p.(Thr328Lys)
Unknown
ACMG
pathogenic
g.176831232G>T
g.177404231G>T
-
-
F12_000008
The c.983C>A variant meets the ACMG criteria to be characterized pathogenic PP1, PM1, PM5, PS3, PS4_Mod
Journal: Gomez-Traseira 2010
-
-
Germline
yes
-
-
-
-
DNA
SEQ
blood
-
HAE3
-
Journal: Gomez-Traseira 2010
Single family: Five affected individuals within 11 carriers
F
no
Spain
-
-
-
-
-
5
Christian Drouet
+/+
9
c.983C>A
r.(?)
p.(Thr328Lys)
Unknown
ACMG
pathogenic
g.176831232G>T
g.177404231G>T
-
-
F12_000008
The c.983C>A variant meets the ACMG criteria to be characterized pathogenic PP1, PM1, PM5, PS3, PS4_Mod
Journal: Mansi 2015
ClinVar-SCV002240385.3
rs118204456
Germline
yes
-
-
-
-
DNA
SEQ
blood
-
HAE3
-
Journal: Mansi 2015
Three independent families, 3 affected individuals, presenting with a HAE-F12 phenotype
-
no
Italy
-
-
-
-
-
3
Christian Drouet
+/+
9
c.983C>A
r.(?)
p.(Thr328Lys)
Unknown
ACMG
pathogenic
g.176831232G>T
g.177404231G>T
-
-
F12_000008
-
Journal: Stieber 2015
ClinVar-SCV001441472.1
rs118204456
Germline
yes
0.000004271
-
-
-
DNA
SEQ
blood
-
HAE3
-
Journal: Stieber 2015
First report of a Brazilian family and of 12 affected individuals presenting with a HAE-F12 phenotype
-
no
Brazil
-
-
-
-
-
12
Christian Drouet
+/+
9
c.983C>A
r.(?)
p.(Thr328Lys)
Unknown
ACMG
pathogenic
g.176831232G>T
g.177404231G>T
-
-
F12_000008
The c.983C>A variant meets the ACMG criteria to be characterized pathogenic PP1, PM1, PM5, PS3, PS4_Mod
Journal: Bork 2017
-
rs118204456
Germline
yes
0.000004
-
-
-
DNA
SEQ
blood
-
HAE3
-
Journal: Bork 2017
One family with 4 affected individuals
-
no
Germany
-
-
-
-
-
4
Christian Drouet
+/+
9
c.983C>A
r.(?)
p.(Thr328Lys)
Unknown
ACMG
pathogenic
g.176831232G>T
g.177404231G>T
-
-
F12_000008
-
Journal: Lochbaum 2023
-
rs118204456
Germline
-
0.000004
-
-
-
DNA
SEQ
blood
-
HAE3
-
Journal: Lochbaum 2023
Clinical presentation: abdominal edema and edema of the limbs under estrogen intake
F
no
Germany
-
-
-
-
-
1
Christian Drouet
+/+
9
c.983C>A
r.(?)
p.(Thr328Lys)
Unknown
ACMG
pathogenic
g.176831232G>T
g.177404231G>T
-
-
F12_000008
Clinical presentation: Recurrent edema of the limbs, lips, face, abdomen, lasting approx. five days. The c.983C>A variant meets the ACMG criteria to be characterized pathogenic PP1, PM1, PM5, PS3, PS4_Mod
Journal: Lochbaum 2023
-
rs118204456
Germline
yes
0.000004
-
-
-
DNA
SEQ
blood
-
HAE3
-
Journal: Lochbaum 2023
Single family with a single affected female individual presenting with recurrent edema of the limbs, lips, face, abdomen, lasting approx. five days
F
no
Germany
-
-
-
-
-
1
Christian Drouet
+/+
9
c.983C>A
r.(?)
p.(Thr328Lys)
Unknown
ACMG
pathogenic
g.176831232G>T
g.177404231G>T
-
-
F12_000008
A Portugese population with 38 probands carrying a c.983C>A variant. The c.983C>A variant meets the ACMG criteria to be characterized pathogenic PP1, PM1, PM5, PS3, PS4_Mod
Journal: Dias de Castro 2024
ClinVar-SCV002240385.3
rs118204456
Germline
yes
0.000004
-
-
-
DNA
SEQ
blood
-
HAE3
-
Journal: Dias de Castro 2024
A population of 38 probands, presumably 38 families, has been shown as carrying a c.953C>A variant
-
no
Portugal
-
-
-
-
-
38
Christian Drouet
+/+
9
c.983C>A
r.(?)
p.(Thr328Lys)
Unknown
ACMG
pathogenic
g.176831232G>T
g.177404231G>T
-
-
F12_000008
The c.983C>A variant meets the ACMG criteria to be characterized pathogenic PP1, PM1, PM5, PS3, PS4_Mod
Journal: Saddouk 2024
-
rs11820445
Germline
yes
-
-
-
-
DNA
SEQ
-
-
HAE3
-
Journal: Saddouk 2024
Case report of HAE-FXII diagnosed during pregnancy with details on the management of recurring attacks in a resource-limited setting with no C1-INH concentrate availability.
F
no
Morocco
-
-
-
-
-
2
Christian Drouet
+/+
9
c.983C>A
r.(?)
p.(Thr328Lys)
Unknown
ACMG
pathogenic
g.176831232G>T
g.177404231G>T
-
-
F12_000008
-
Journal: Lekhlit 2025
-
-
Germline
yes
-
-
-
-
DNA
SEQ
-
-
HAE3
-
Journal: Lekhlit 2025
Single individual
F
no
Morocco
-
-
-
-
-
1
Christian Drouet
+/+
9
c.983C>A
r.(?)
p.(Thr328Lys)
Unknown
ACMG
pathogenic
g.176831232G>T
g.177404231G>T
p.Thr328Lys
-
F12_000008
-
Journal: Veronez 2019
-
-
Germline
yes
-
-
-
-
DNA
SEQ
-
-
HAE3
-
Journal: Veronez 2019
Single family
F
no
Brazil
-
-
-
-
-
1
Christian Drouet
+/+
9
c.983C>A
r.(?)
p.(Thr328Lys)
Unknown
ACMG
pathogenic
g.176831232G>T
g.177404231G>T
-
-
F12_000008
First report of a Mexican family with 12 carriers - 8 women and 4 men, including an asymptomatic male carrier.
Journal: Contreras-Verduzco 2023
-
-
Germline
yes
-
-
-
-
DNA
SEQ
-
-
HAE3
-
Journal: Contreras-Verduzco 2023
First description of a Mexican HAE-FXII family.
F
no
Mexico
-
-
-
-
-
12
Christian Drouet
+/+
9
c.983C>A
r.(?)
p.(Thr328Lys)
Unknown
ACMG
pathogenic
g.176831232G>T
g.177404231G>T
-
-
F12_000008
-
Journal: García Robledo 2025
-
-
Germline
yes
-
-
-
-
DNA
SEQ
-
-
HAE3
-
Journal: García Robledo 2025
A single pregnant female individual suffering from HAE during labor induction
F
no
Spain
-
-
-
-
-
1
Christian Drouet
10 per page
25 per page
50 per page
100 per page
Legend
How to query
Screenscraping/webscraping (downloading large amounts of data using scripts) is strictly prohibited.
Use our
APIs
to retrieve data.
Powered by
LOVD v.3.0
Build 30b
LOVD software ©2004-2024
Leiden University Medical Center
Database contents © by their respective submitters and curators